loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

List of Certificates of Suitability (CEPs) for cep_2023_345___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-Lin TW (1)

filter

01 Tacrolimus monohydrate, Process B (1)

filter

01 Taiwan (1)

filter

01 Valid (1)

Looking for Certificates of Suitability (CEPs) for CEP 2023-345 - Rev 00 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw

Looking for Certificates of Suitability (CEPs) for CEP 2023-345 - Rev 00 of Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw 1

20

Chunghwa Chemical Synthesis & Biotech Co., Ltd. Shu-lin Tw, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Tacrolimus monohydrate, Process B, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-345 - Rev 00

This Chemical Type CEP, issued on March 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2244 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY